WebAbout us. Biotheus (普米斯生物技术) aims to discover and develop effective therapeutic biologics for patients with cancer and inflammatory disease. We believe in creative … WebFeb 1, 2024 · In December 2024, Biotheus Inc. announced that its proprietary anti-PD-L1/TGF-β bifunctional therapeutic, named PM8001, has been approved by the USFDA (United States Food and Drug Administration)...
TILT Biotherapeutics Signs a Licensing Deal with Biotheus, …
WebDec 3, 2024 · About Biotheus Inc. Biotheus Inc. is a biotechnology company based in Zhuhai, Guangdong, China with multiple clinical-stage assets under clinical development. Biotheus' management team has broad experience from drug discovery to NDA filing in the US and China and is developing a broad me-better/novel target pipeline focused on … WebNov 7, 2024 · MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced a collaboration with Biotheus, a China-based biotech company focused on developing treatments for cancer and autoimmune diseases. greeting flowers images
Biotheus
WebNov 15, 2024 · Biotheus Inc. is a clinical-stage biotech company established in 2024 and is committed to the development and commercialization of novel antibodies and cell … WebNov 7, 2024 · Biotheus Inc. Study Details Tabular View No Results Posted Disclaimer How to Read a Study Record Study Description Go to Brief Summary: The study is being conducted to evaluate safety, tolerability, pharmacokinetics and preliminary efficacy of PM1009 for patients with advanced tumors, also to explore the recommended Phase Ⅱ … WebApr 12, 2024 · Utlicensierade program inkluderar AC101/HLX22, i fas 2-utveckling, till Shanghai Henlius Biotech Inc. och en ej offentliggjord målmolekyl till Biotheus Inc. Alligator Biosciences aktier handlas på Nasdaq Stockholm under tickern ”ATORX”. Huvudkontoret är beläget i Lund. För mer information, vänligen besök alligatorbioscience.com. greeting for 60th birthday card